Selected research
Market Outlook & Growth Opportunities
Global Phosphate Buffered Saline (PBS) Tablet Market Outlook and Growth Opportunities 2026
Market perspective
The global Phosphate Buffered Saline (PBS) Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Phosphate Buffered Saline (PBS) Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Phosphate Buffered Saline (PBS) Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Phosphate Buffered Saline (PBS) Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Phosphate Buffered Saline (PBS) Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Phosphate Buffered Saline (PBS) Tablet market include Merck, Valiant, Tocris Bioscience, Thermo Fisher, Takara Bio, Spectrum Chemical, R-Biopharm AG, R&D Systems and Novus Biologicals, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Phosphate Buffered Saline (PBS) Tablet market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Phosphate Buffered Saline (PBS) Tablet and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Phosphate Buffered Saline (PBS) Tablet revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Phosphate Buffered Saline (PBS) Tablet market.
Phosphate Buffered Saline (PBS) Tablet Segment by Company
Merck
Valiant
Tocris Bioscience
Thermo Fisher
Takara Bio
Spectrum Chemical
R-Biopharm AG
R&D Systems
Novus Biologicals
MyBioSource
Medicago AB
Bio Basic
Phosphate Buffered Saline (PBS) Tablet Segment by Type
Soluble in 500ML Water
Soluble in 200ML Water
Soluble in 100ML Water
Others
Phosphate Buffered Saline (PBS) Tablet Segment by Application
University Laboratory
Business Research Institute
Others
Phosphate Buffered Saline (PBS) Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Phosphate Buffered Saline (PBS) Tablet status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Phosphate Buffered Saline (PBS) Tablet key companies, revenue, market share, and recent developments.
3. To split the Phosphate Buffered Saline (PBS) Tablet breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Phosphate Buffered Saline (PBS) Tablet market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Phosphate Buffered Saline (PBS) Tablet significant trends, drivers, influence factors in global and regions.
6. To analyze Phosphate Buffered Saline (PBS) Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphate Buffered Saline (PBS) Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phosphate Buffered Saline (PBS) Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphate Buffered Saline (PBS) Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phosphate Buffered Saline (PBS) Tablet industry.
Chapter 3: Detailed analysis of Phosphate Buffered Saline (PBS) Tablet company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Phosphate Buffered Saline (PBS) Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Phosphate Buffered Saline (PBS) Tablet in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Soluble in 500ML Water
- Soluble in 200ML Water
- Soluble in 100ML Water
- Others
Applications
- University Laboratory
- Business Research Institute
- Others
Companies covered
- Merck
- Valiant
- Tocris Bioscience
- Thermo Fisher
- Takara Bio
- Spectrum Chemical
- R-Biopharm AG
- R&D Systems
- Novus Biologicals
- MyBioSource
- Medicago AB
- Bio Basic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Phosphate Buffered Saline (PBS) Tablet Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Phosphate Buffered Saline (PBS) Tablet Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Phosphate Buffered Saline (PBS) Tablet Market Dynamics
- 2.1 Phosphate Buffered Saline (PBS) Tablet Industry Trends
- 2.2 Phosphate Buffered Saline (PBS) Tablet Industry Drivers
- 2.3 Phosphate Buffered Saline (PBS) Tablet Industry Opportunities and Challenges
- 2.4 Phosphate Buffered Saline (PBS) Tablet Industry Restraints
3 Phosphate Buffered Saline (PBS) Tablet Market by Company
- 3.1 Global Phosphate Buffered Saline (PBS) Tablet Company Revenue Ranking in 2025
- 3.2 Global Phosphate Buffered Saline (PBS) Tablet Revenue by Company (2021-2026)
- 3.3 Global Phosphate Buffered Saline (PBS) Tablet Company Ranking (2024-2026)
- 3.4 Global Phosphate Buffered Saline (PBS) Tablet Company Manufacturing Base and Headquarters
- 3.5 Global Phosphate Buffered Saline (PBS) Tablet Company Product Type and Application
- 3.6 Global Phosphate Buffered Saline (PBS) Tablet Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Phosphate Buffered Saline (PBS) Tablet Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Phosphate Buffered Saline (PBS) Tablet Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Phosphate Buffered Saline (PBS) Tablet Market by Type
- 4.1 Phosphate Buffered Saline (PBS) Tablet Type Introduction
- 4.1.1 Soluble in 500ML Water
- 4.1.2 Soluble in 200ML Water
- 4.1.3 Soluble in 100ML Water
- 4.1.4 Others
- 4.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type
- 4.2.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Type (2021-2032)
- 4.2.3 Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type (2021-2032)
5 Phosphate Buffered Saline (PBS) Tablet Market by Application
- 5.1 Phosphate Buffered Saline (PBS) Tablet Application Introduction
- 5.1.1 University Laboratory
- 5.1.2 Business Research Institute
- 5.1.3 Others
- 5.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application
- 5.2.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Application (2021-2032)
- 5.2.3 Global Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application (2021-2032)
6 Phosphate Buffered Saline (PBS) Tablet Regional Value Analysis
- 6.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region (2021-2032)
- 6.2.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region: 2021-2026
- 6.2.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
- 6.3.2 North America Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
- 6.4.2 Europe Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
- 6.6.2 South America Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Country, 2025 VS 2032
7 Phosphate Buffered Saline (PBS) Tablet Country-level Value Analysis
- 7.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country (2021-2032)
- 7.2.1 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country (2021-2026)
- 7.2.2 Global Phosphate Buffered Saline (PBS) Tablet Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.7.2 France Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.14.2 China Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.17.2 India Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Phosphate Buffered Saline (PBS) Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Valiant
- 8.2.1 Valiant Company Information
- 8.2.2 Valiant Business Overview
- 8.2.3 Valiant Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.2.4 Valiant Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.2.5 Valiant Recent Developments
- 8.3 Tocris Bioscience
- 8.3.1 Tocris Bioscience Company Information
- 8.3.2 Tocris Bioscience Business Overview
- 8.3.3 Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.3.4 Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.3.5 Tocris Bioscience Recent Developments
- 8.4 Thermo Fisher
- 8.4.1 Thermo Fisher Company Information
- 8.4.2 Thermo Fisher Business Overview
- 8.4.3 Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.4.4 Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.4.5 Thermo Fisher Recent Developments
- 8.5 Takara Bio
- 8.5.1 Takara Bio Company Information
- 8.5.2 Takara Bio Business Overview
- 8.5.3 Takara Bio Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.5.4 Takara Bio Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.5.5 Takara Bio Recent Developments
- 8.6 Spectrum Chemical
- 8.6.1 Spectrum Chemical Company Information
- 8.6.2 Spectrum Chemical Business Overview
- 8.6.3 Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.6.4 Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.6.5 Spectrum Chemical Recent Developments
- 8.7 R-Biopharm AG
- 8.7.1 R-Biopharm AG Company Information
- 8.7.2 R-Biopharm AG Business Overview
- 8.7.3 R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.7.4 R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.7.5 R-Biopharm AG Recent Developments
- 8.8 R&D Systems
- 8.8.1 R&D Systems Company Information
- 8.8.2 R&D Systems Business Overview
- 8.8.3 R&D Systems Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.8.4 R&D Systems Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.8.5 R&D Systems Recent Developments
- 8.9 Novus Biologicals
- 8.9.1 Novus Biologicals Company Information
- 8.9.2 Novus Biologicals Business Overview
- 8.9.3 Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.9.4 Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.9.5 Novus Biologicals Recent Developments
- 8.10 MyBioSource
- 8.10.1 MyBioSource Company Information
- 8.10.2 MyBioSource Business Overview
- 8.10.3 MyBioSource Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.10.4 MyBioSource Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.10.5 MyBioSource Recent Developments
- 8.11 Medicago AB
- 8.11.1 Medicago AB Company Information
- 8.11.2 Medicago AB Business Overview
- 8.11.3 Medicago AB Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.11.4 Medicago AB Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.11.5 Medicago AB Recent Developments
- 8.12 Bio Basic
- 8.12.1 Bio Basic Company Information
- 8.12.2 Bio Basic Business Overview
- 8.12.3 Bio Basic Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
- 8.12.4 Bio Basic Phosphate Buffered Saline (PBS) Tablet Product Portfolio
- 8.12.5 Bio Basic Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst